{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:24:51Z","timestamp":1787826291422,"version":"build-2784847793"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Polymer drug conjugates (PDCs) represent a targeted modification of conventional\nchemotherapeutics, transforming small-molecule drugs like doxorubicin (dox) into macromolecular\nstructures with significantly altered biological properties. By incorporating a biocompatible polymer\nbackbone, a cleavable linker, and an active cytotoxic payload, PDCs achieve prolonged systemic\npersistence, advantageous biodistribution, and tumor-specific release. This architecture facilitates\nmore reliable exploitation of the enhanced permeability and retention (EPR) effect, thereby encouraging\npreferential intratumoral accumulation while reducing off-target exposure. The regulated and\nmicroenvironment-sensitive release of dox provides a logical approach to mitigate cardiotoxicity, a\nsignificant limitation of anthracycline treatment. PDCs can partially bypass efflux-mediated multidrug\nresistance by using endocytic uptake pathways rather than transporter-dependent mechanisms.\nPrototypical systems such as HPMA-dox and PEG-dox offer persuasive translational evidence that\nmacromolecular conjugation can enhance the therapeutic index of dox. PDCs collectively demonstrate\nhow advanced molecular engineering might rejuvenate traditional chemotherapeutics for contemporary\noncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113895575471485260408204857","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T17:52:21Z","timestamp":1776621141000},"page":"1071-1075","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polymer-doxorubicin Conjugates: Redefining Chemotherapy for Breast Cancer"],"prefix":"10.2174","volume":"26","author":[{"given":"Sneha","family":"Kumari","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Quality Assurance, ISF College of Pharmacy, GT Road, Moga, 142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga, 142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Mustahidul","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, ISF College of Pharmacy, GT Road, Moga, 142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga, 142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, ISF College of Pharmacy, GT Road, Moga, 142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-6622","authenticated-orcid":true,"given":"Balak Das","family":"Kurmi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga, 142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.3390\/cancers17142303","volume":"17","author":"Bhadran A.","year":"2025","unstructured":"Bhadran A.; Polara H.; Babanyinah G.K.; Baburaj S.; Stefan M.C.; Advances in doxorubicin chemotherapy: Emerging polymeric nanocarriers for drug loading and delivery. Cancers  2025,17(14),2303","journal-title":"Cancers"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s12672-024-01509-9","volume":"15","author":"Parashar A.K.","year":"2024","unstructured":"Parashar A.K.; Saraogi G.K.; Jain P.K.; Kurmi B.; Shrivastava V.; Arora V.; Polymer-drug conjugates: Revolutionizing nanotheranostic agents for diagnosis and therapy. Discov Oncol  2024,15(1),641","journal-title":"Discov Oncol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"125556","DOI":"10.1016\/j.ijpharm.2025.125556","volume":"675","author":"Gautam S.","year":"2025","unstructured":"Gautam S.; Joshi S.; Jindal P.; Patel P.; Pal R.R.; Kumar M.; Gupta G.D.; Kurmi B.D.; Recent doxorubicin-conjugates in cancer drug delivery: Exploring conjugation strategies for enhanced efficacy and reduced toxicity. Int J Pharm  2025,675,125556","journal-title":"Int J Pharm"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","volume":"18","author":"Ekladious I.","year":"2019","unstructured":"Ekladious I.; Colson Y.L.; Grinstaff M.W.; Polymer\u2013drug conjugate therapeutics: Advances, insights and prospects. Nat Rev Drug Discov  2019,18(4),273-294","journal-title":"Nat Rev Drug Discov"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1080\/07391102.2016.1222971","volume":"35","author":"Sanyakamdhorn S.","year":"2017","unstructured":"Sanyakamdhorn S.; Agudelo D.; Tajmir-Riahi H.A.; Review on the targeted conjugation of anticancer drugs doxorubicin and tamoxifen with synthetic polymers for drug delivery. J Biomol Struct Dyn  2017,35(11),2497-2508","journal-title":"J Biomol Struct Dyn"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"9367","DOI":"10.2174\/0109298673320170240829110110","volume":"32","author":"Deng S.","year":"2025","unstructured":"Deng S.; Wen X.; Wang J.; Recent advances in the linkers of drug conjugates. Curr Med Chem  2025,32(41),9367-9386","journal-title":"Curr Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1021\/cm2031569","volume":"24","author":"Larson N.","year":"2012","unstructured":"Larson N.; Ghandehari H.; Polymeric conjugates for drug delivery. Chem Mater  2012,24(5),840-853","journal-title":"Chem Mater"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.drudis.2020.06.028","volume":"25","author":"Thakor P.","year":"2020","unstructured":"Thakor P.; Bhavana V.; Sharma R.; Srivastava S.; Singh S.B.; Mehra N.K.; Polymer\u2013drug conjugates: Recent advances and future perspectives. Drug Discov Today  2020,25(9),1718-1726","journal-title":"Drug Discov Today"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/jpm8010006","volume":"8","author":"Atkinson S.","year":"2018","unstructured":"Atkinson S.; Andreu Z.; Vicent M.; Polymer therapeutics: Biomarkers and new approaches for personalized cancer treatment. J Pers Med  2018,8(1),6","journal-title":"J Pers Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/adt.2022.102","volume":"21","author":"Sandal P.","year":"2023","unstructured":"Sandal P.; Kumari L.; Patel P.; Singh A.; Singh D.; Gupta G.D.; Kurmi B.D.; Doxorubicin conjugates: An efficient approach for enhanced therapeutic efficacy with reduced side effects. Assay Drug Dev Technol  2023,21(4),137-156","journal-title":"Assay Drug Dev Technol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/sj.bjc.6602204","volume":"91","author":"Matsumura Y.","year":"2004","unstructured":"Matsumura Y.; Hamaguchi T.; Ura T.; Muro K.; Yamada Y.; Shimada Y.; Shirao K.; Okusaka T.; Ueno H.; Ikeda M.; Watanabe N.; Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer  2004,91(10),1775-1781","journal-title":"Br J Cancer"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12645-024-00275-1","volume":"15","author":"Farhoudi L.","year":"2024","unstructured":"Farhoudi L.; Hosseinikhah S.M.; Kazemi-Beydokhti A.; Arabi L.; Alavizadeh S.H.; Moosavian S.A.; Jaafari M.R.; pH-sensitive polymeric micelles enhance the co-delivery of doxorubicin and docetaxel: An emerging modality for treating breast cancer. Cancer Nanotechnol  2024,15(1),37","journal-title":"Cancer Nanotechnol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"124724","DOI":"10.1016\/j.ijpharm.2024.124724","volume":"666","author":"Liu Y.","year":"2024","unstructured":"Liu Y.; Craig D.Q.M.; Parhizkar M.; Controlled release of doxorubicin from Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by coaxial electrospraying. Int J Pharm  2024,666,124724","journal-title":"Int J Pharm"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"102124","DOI":"10.1016\/j.nano.2019.102124","volume":"24","author":"Zhao Y.","year":"2020","unstructured":"Zhao Y.; Alakhova D.Y.; Zhao X.; Band V.; Batrakova E.V.; Kabanov A.V.; Eradication of cancer stem cells in triple negative breast cancer using doxorubicin\/pluronic polymeric micelles. Nanomedicine  2020,24,102124","journal-title":"Nanomedicine"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"100605","DOI":"10.1016\/j.ctarc.2022.100605","volume":"32","author":"Salari N.","year":"2022","unstructured":"Salari N.; Faraji F.; Torghabeh F.M.; Faraji F.; Mansouri K.; Abam F.; Shohaimi S.; Akbari H.; Mohammadi M.; Polymer-based drug delivery systems for anticancer drugs: A systematic review. Cancer Treat Res Commun  2022,32,100605","journal-title":"Cancer Treat Res Commun"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/IJN.S429279","volume":"20","author":"Ullah A.","year":"2025","unstructured":"Ullah A.; Khan M.; Zhang Y.; Shafiq M.; Ullah M.; Abbas A.; Xianxiang X.; Chen G.; Diao Y.; Advancing therapeutic strategies with polymeric drug conjugates for nucleic acid delivery and treatment. Int J Nanomed  2025,20,25-52","journal-title":"Int J Nanomed"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s11864-025-01343-3","volume":"26","author":"Chattopadhyay A.","year":"2025","unstructured":"Chattopadhyay A.; Goyal F.; Sehrawat A.; Sidhu I.S.; Monga V.; Bhatti G.K.; Bhatti J.S.; Revolutionizing breast cancer therapeutics: Intersecting frontiers of precision medicine, nanotechnology, and drug delivery innovations. Curr Treat Options Oncol  2025,26(9),775-796","journal-title":"Curr Treat Options Oncol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"115550","DOI":"10.1016\/j.addr.2025.115550","volume":"219","author":"Belyaev I.B.","year":"2025","unstructured":"Belyaev I.B.; Griaznova O.Y.; Yaremenko A.V.; Deyev S.M.; Zelepukin I.V.; Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors. Adv Drug Deliv Rev  2025,219,115550","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"214636","DOI":"10.1016\/j.bioadv.2025.214636","volume":"181","author":"Khan M.S.","year":"2026","unstructured":"Khan M.S.; Alqahtani T.; Al Shmrany H.; Gupta G.; Goh K.W.; Sahebkar A.; Kesharwani P.; Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targeting. Biomater Adv  2026,181,214636","journal-title":"Biomater Adv"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"11121","DOI":"10.3390\/ijms262211121","volume":"26","author":"Han Y.","year":"2025","unstructured":"Han Y.; Kim D.H.; Pack S.P.; Nanomaterials in drug delivery: Leveraging Artificial Intelligence and big data for predictive design. Int J Mol Sci  2025,26(22),11121","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"10143","DOI":"10.1002\/btm2.10143","volume":"4","author":"Anselmo A.C.","year":"2019","unstructured":"Anselmo A.C.; Mitragotri S.; Nanoparticles in the clinic: An update. Bioeng Transl Med  2019,4(3),10143","journal-title":"Bioeng Transl Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.61882\/ibj.4960","volume":"29","author":"Tarighi P.","year":"2025","unstructured":"Tarighi P.; Mousavi Esfahani M.; Emamjomeh A.; Mirjalili Z.; Mirzabeygi P.; Optimizing cancer treatment: A comprehensive review of active and passive drug delivery strategies. Iran Biomed J  2025,29(4),173-188","journal-title":"Iran Biomed J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.3390\/cancers14092144","volume":"14","author":"Bae J.","year":"2022","unstructured":"Bae J.; Choi Y.S.; Cho G.; Jang S.J.; The patient-derived cancer organoids: Promises and challenges as platforms for cancer discovery. Cancers  2022,14(9),2144","journal-title":"Cancers"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"100625","DOI":"10.1016\/j.cobme.2025.100625","volume":"36","author":"Azimi S.","year":"2025","unstructured":"Azimi S.; Intelligent nanoparticle design: Unlocking the potential of AI for transformative drug delivery. Curr Opin Biomed Eng  2025,36,100625","journal-title":"Curr Opin Biomed Eng"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2020.11.009","volume":"171","author":"Upadhya R.","year":"2021","unstructured":"Upadhya R.; Kosuri S.; Tamasi M.; Meyer T.A.; Atta S.; Webb M.A.; Gormley A.J.; Automation and data-driven design of polymer therapeutics. Adv Drug Deliv Rev  2021,171,1-28","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575471485260408204857","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/252457\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575471485260408204857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:06:06Z","timestamp":1787825166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/252457\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":25,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113895575471485260408204857","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}